The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective
Open accessAbstract
Summary On October 11, 2013, the Framingham Heart Study will celebrate 65 years since the examination of its first participant in 1948. During this period, the study has provided substantial insight into the epidemiology of cardiovascular disease and its risk factors. The origin of the study is closely linked to the cardiovascular health of President Franklin D. Roosevelt and his premature death from hypertensive heart disease and stroke in 1945. The present article describes the events leading to the founding of the Framingham Heart Study, and provides a brief historical overview of selected contributions from the study.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 83 cited sources checked · 0 supported · 0 flagged
- Findingcitation
In 1971, analysis of 14 years of follow-up showed that rising baseline blood pressure increased the risk of coronary heart disease morbidity.
“In 1971, Framingham investigators analyzed 14 years of follow-up data to demonstrate increased risk of coronary heart disease morbidity with rising baseline blood pressure.42”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [42] Finenberg, 1927, Systolic hypertension. Its relationship to atherosclerosis of the aorta and larger arteries, Am J Med Sci source
Not checked in the free run.
- Findingcitation
High blood pressure also had stroke as a major consequence.
“A few years later they noted that stroke was also a major consequence of high blood pressure.27”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [27] Kannel, 1961, Factors of risk in the development of coronary heart disease—six year follow-up experience, Ann Intern Med source
Not checked in the free run.
- Findingnone given
By the end of the 8th Framingham examination cycle in 1966, investigators had observed a rising prevalence of heart failure in the cohort.
“By the end of the 8th Framingham examination cycle in 1966, investigators had noted a rising prevalence of heart failure in the cohort.”
Quote in the paperSubstantial claim - Findingcitation
In the 1967 Framingham risk function, the top decile compared with the lowest decile had a thirtyfold (men) to seventyfold (women) difference in coronary heart disease incidence.
“Individuals in the top decile compared with the lowest decile had a thirty-fold (men) to seventy-fold (women) difference in the incidence of coronary heart disease.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [48] Staessen, 1997, Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension, Lancet source
Not checked in the free run.
- Findingown data
More than half of the original cohort participants were women.
“Women comprised more than half of all participants.”
Quote in the paperNot a substantial claim
- Findingown data
When systolic and diastolic pressures were compared for coronary heart disease events, systolic pressure was more strongly linked than diastolic pressure.
“When systolic and diastolic pressures were studied for association with coronary heart disease events, systolic pressure demonstrated a stronger link than diastolic pressure (Figure 4).”
Quote in the paperSubstantial claim - Premisecitation
Thomas Dawber and William Kannel popularized the term 'risk factor' in the medical lexicon through their 1961 publication.
“Indeed, the term “risk factor” was popularized in the medical lexicon by Thomas Dawber and William Kannel by their 1961 publication, “Factors of Risk in the Development of Coronary Heart Disease.”25”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [25] Keys, 1989, Longevity of man: relative weight and fatness in middle age, Ann Med source
Not checked in the free run.
- Premisecitation
The 10-year risk estimates in the 1998 Framingham score classified people as low, intermediate, or high risk for future coronary heart disease.
“The 10-year risk estimates used in the 1998 score provided a convenient way to classify individuals as low, intermediate, or high risk for future coronary heart disease.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [50] Kannel, 1976, A general cardiovascular risk profile: the Framingham study, Am J Cardiol source
Not checked in the free run.
- Premisecitation
Until the late 1960s, heart failure research was limited by inconsistent diagnostic criteria.
“Until the late 1960s, research on heart failure was hampered by a lack of consistent diagnostic criteria.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [52] 2002
Not checked in the free run.
- cites [53] Gibson, 1966, The prevalence of congestive heart failure in two rural communities, J Chronic Dis source
Not checked in the free run.
- Premisecitation
The 1977 Joint National Committee report still recommended diastolic blood pressure as the basis for diagnosing and treating hypertension.
“The Committee still recommended diastolic blood pressure as the basis for diagnosis and treatment of hypertension, but over the next decade, the emphasis on diastolic blood pressure as the principal treatment target was dropped after randomized controlled trials demonstrated the cardiovascular benefits of systolic blood pressure reduction.46,47”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [45] Kannel, 1972, Role of blood pressure in the development of congestive heart failure. The Framingham study, N Engl J Med source
Not checked in the free run.
- Premisecitation
The Framingham study included women, unlike contemporaneous epidemiological studies that had few or no women.
“The study's inclusion of women contrasted with contemporaneous epidemiological studies, which had very small numbers of women or excluded them altogether.23,24”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [23] Keys, 1960, Serum cholesterol and relative body weight of coronary patients in different populations, Circulation source
Not checked in the free run.
- cites [24] Chapman, 1957, IV. Measuring the risk of coronary heart disease in adult population groups. The clinical status of a population group in Los Angeles under observation for two to three years, Am J Public Health Nations Health source
Not checked in the free run.
- Premisecitation
Framingham was regarded as representative of the United States in the 1940s.
“was therefore considered to be representative of the United States in the 1940s.15 p1b-5”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [15] Dawber, 1951, Epidemiological approaches to heart disease: the Framingham study, Am J Public Health Nations Health source
Not checked in the free run.
- Premisecitation
The National Heart Institute took control of the study within a few months of the first examination.
“Within a few months of the first examination, the newly-established National Heart Institute assumed control of the study.15 p1c-2”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [15] Dawber, 1951, Epidemiological approaches to heart disease: the Framingham study, Am J Public Health Nations Health source
Not checked in the free run.
- Premisecitation
The 1998 Wilson Framingham Risk Score for coronary heart disease became the basis of the risk calculator adopted by the Adult Treatment Panel of the National Cholesterol Education Program in the United States.
“The best known risk profile is the Framingham Risk Score for coronary heart disease, published in 1998 by Wilson and colleagues.50 This function became the basis of the risk calculator adopted by the Adult Treatment Panel of the National Cholesterol Education Program in the United States.51”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
The Framingham Heart Study examined its first participant on October 11, 1948.
“On October 11, 2013, the Framingham Heart Study will celebrate 65 years since the examination of its first participant in 1948.”
- Also stated in: § Choosing a location · plain
“On October 11, 1948 the study officially examined its first Framingham participant, exactly 12 months after Gilcin Meadors' arrival in Massachusetts.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [20] Meadors, 1948
Not checked in the free run.
- Also stated in: § Choosing a location · plain
- Study design and conductcitation
The Framingham heart failure criteria were applied to nearly two decades of data in which staff had already recorded whether they clinically suspected heart failure.
“They therefore developed a set of clinical criteria for heart failure (Table 2), which were applied to nearly two decades of collected data where staff had already been noting whether they clinically suspected participants of having heart failure.54,55”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [54] Benack, 1969, Etiology of congestive heart failure in clinical medicine, Ann NY Acad Sci source
Not checked in the free run.
- cites [55] 1968
Not checked in the free run.
- Premisecitation
Roosevelt had heart failure caused by risk factors that were undiagnosed and later untreated.
“suffering from heart failure due to undiagnosed, and later untreated, risk factors.5”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [5] Bruenn, 1970, Clinical notes on the illness and death of President Franklin D. Roosevelt, Ann Intern Med source
Not checked in the free run.
- Interpretationreasoning
The study's founding was connected to President Franklin D. Roosevelt's cardiovascular illness and his death in 1945.
“The origin of the study is closely linked to the cardiovascular health of President Franklin D. Roosevelt and his premature death from hypertensive heart disease and stroke in 1945.”
- Also stated in: § Origins of the Framingham Heart Study · hedged
“These events likely played a role in prompting the creation of the Framingham Heart Study in 1948.”
Quote in the paperNot a substantial claim - Also stated in: § Origins of the Framingham Heart Study · hedged
- Interpretationcitation
Hypertension was the leading risk factor for heart failure.
“In 1971, McKee and Kannel used the newly described criteria to show for the first time that hypertension was in fact the leading risk factor for heart failure (Figure 5).56”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [56] McNamara, 1967
Not checked in the free run.
- Premisecitation
The first Framingham risk profile, published in 1976 by Kannel and colleagues, covered a general cardiovascular endpoint including coronary heart disease, stroke, claudication, and heart failure.
“The first risk profile was published in 1976 by Kannel and colleagues, and covered a general cardiovascular endpoint that included coronary heart disease, stroke, claudication, and heart failure.49”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [49] Truett, 1967, A multivariate analysis of the risk of coronary heart disease in Framingham, J Chronic Dis source
Not checked in the free run.
- Premisecitation
The Framingham Heart Study was the first long-term study of its kind, except for Sir James Mackenzie's aborted attempt to follow St. Andrews residents.
“The Framingham Heart Study was the first long-term study of its kind, with the exception of Sir James Mackenzie's aborted attempt to longitudinally follow the health status of St. Andrews, Scotland residents.21”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [21] Waterston, 1939, Sir James Mackenzie's heart, Br Heart J source
Not checked in the free run.
- Study design and conductreasoning
The study switched from volunteer solicitation to active recruitment of a random sample of town adults because estimating disease prevalence required random sampling.
“Additionally, realizing that population prevalence of diseases required random sampling, he changed the methodology from soliciting volunteers to active recruitment of a random sample of town adults.”
Quote in the paperNot a substantial claim - Premisecitation
The Framingham heart failure criteria have been used continuously in Framingham and many other cohorts worldwide since the late 1960s.
“Since their development in the late 1960s, these criteria have been in continuous use, not only in Framingham but in multiple cohorts around the world. 57”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [57] McKee, 1971, The natural history of congestive heart failure: the Framingham study, N Engl J Med source
Not checked in the free run.
- Premisecitation
In 1999, Vasan et al. reported that about half of Framingham participants with heart failure had normal ejection fraction (>50%) at diagnosis.
“In 1999, Vasan and colleagues reported that approximately half of Framingham participants with heart failure had a normal ejection fraction (>50%) at the time of diagnosis.62”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [62] Hunt, 2005, Circulation source
Not checked in the free run.
- Interpretationreasoning
Clinical manifestations of heart failure can be present without left ventricular systolic dysfunction.
“It also became apparent that clinical manifestations of heart failure can be present in the absence of left ventricular systolic dysfunction.”
Quote in the paperSubstantial claim - Premisecitation
The 1998 Framingham Risk Score, adopted by the National Cholesterol Education Program, contained both total and HDL cholesterol.
“Notably, the 1998 version of the Framingham Risk Score, adopted by the National Cholesterol Education Program, contained both total and HDL cholesterol.50”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [50] Kannel, 1976, A general cardiovascular risk profile: the Framingham study, Am J Cardiol source
Not checked in the free run.
- Premisecitation
Framingham studies documented alterations in cardiac structure or function that precede overt heart failure.
“Other studies from Framingham documented alterations in cardiac structure or function that preceded overt heart failure.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [59] Levy, 2002, Long-term trends in the incidence of and survival with heart failure, N Engl J Med source
Not checked in the free run.
- cites [60] Vasan, 1997, Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction, N Engl J Med source
Not checked in the free run.
- Premisecitation
In Framingham, cardiovascular mortality was 3-fold higher for individuals with diabetes.
“In Framingham, cardiovascular mortality was 3 fold higher for individuals with diabetes.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [68] Keen, 1965, Blood-sugar and arterial disease, Lancet source
Not checked in the free run.
- Premisecitation
Framingham demonstrated an association between diabetes and vascular disease.
“By the middle of the century, clinical data had emerged on the link between diabetes and vascular disease,65-67 an association also demonstrated in Framingham.68”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [68] Keen, 1965, Blood-sugar and arterial disease, Lancet source
Not checked in the free run.
- Premisecitation
In Framingham, 5-year mortality after heart failure declined in women from 57% in 1950 to 45% in 1999.
“Using 50 years of follow up data, Levy and colleagues reported that the 5 year mortality declined in men from 70% in 1950 to 59% in 1999, and in women from 57% to 45%.58”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [58] Levy, 1996, The progression from hypertension to congestive heart failure, JAMA source
Not checked in the free run.
- Interpretationreasoning
Atrial fibrillation and heart failure share a number of epidemiological features because they both follow adverse cardiac remodeling.
“Given the similarities between atrial fibrillation and heart failure, two conditions that follow adverse cardiac remodeling, it is not surprising that they share a number of epidemiological features.”
Quote in the paperNot a substantial claim - Premisecitation
Framingham investigators established a link between systolic blood pressure and stroke.
“In addition to establishing the link between systolic blood pressure and stroke,27 investigators showed that the risk of stroke from hypertension was even greater than the conferred risk for coronary heart disease.43”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [27] Kannel, 1961, Factors of risk in the development of coronary heart disease—six year follow-up experience, Ann Intern Med source
Not checked in the free run.
- Premisecitation
In a 1997 Framingham study, increased left ventricular end-diastolic diameter predicted incident heart failure in individuals without myocardial infarction.
“A study in 1997 by Vasan and colleagues demonstrated that increased left ventricular end-diastolic diameter predicted incident heart failure in individuals free of myocardial infarction.59”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [59] Levy, 2002, Long-term trends in the incidence of and survival with heart failure, N Engl J Med source
Not checked in the free run.
- Premisecitation
The risk of stroke from hypertension was greater than the risk for coronary heart disease.
“In addition to establishing the link between systolic blood pressure and stroke,27 investigators showed that the risk of stroke from hypertension was even greater than the conferred risk for coronary heart disease.43”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [43] Kannel, 1971, Systolic versus diastolic blood pressure and risk of coronary heart disease. The Framingham study, Am J Cardiol source
Not checked in the free run.
- Premisecitation
Framingham demonstrated that non-rheumatic atrial fibrillation is a potent risk factor for stroke.
“One of the most valuable clinical contributions from Framingham was the demonstration that non-rheumatic atrial fibrillation was a potent risk factor for stroke.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [79] Kenchaiah, 2002, Obesity and the risk of heart failure, N Engl J Med source
Not checked in the free run.
- Interpretationnone given
The risk factor concept laid the foundation for clinical risk scores.
“The articulation of the risk factor concept laid the foundation for the development of clinical risk scores.”
Quote in the paperSubstantial claim - Interpretationreasoning
Framingham and other cohort studies helped shift the paradigm from treating established cardiovascular disease to preventing disease in at-risk individuals.
“Thus, studies from Framingham and other epidemiological cohorts contributed to a paradigm shift in the latter half of the 20th century, from a focus on treating individuals with established cardiovascular disease to the prevention of disease in those at risk.”
Quote in the paperSubstantial claim - Premisecitation
By the middle of the 20th century, clinical data had emerged on the link between diabetes and vascular disease.
“By the middle of the century, clinical data had emerged on the link between diabetes and vascular disease,65-67 an association also demonstrated in Framingham.68”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [65] Liebow, 1949, Cardiac complications of diabetes mellitus, Am J Med source
Not checked in the free run.
- cites [66] Partamian, 1965, Acute myocardial infarction in 258 cases of diabetes. Immediate mortality and five-year survival, N Engl J Med source
Not checked in the free run.
- cites [67] Liebow, 1955, Arteriosclerotic heart disease in diabetes mellitus; a clinical study of 383 patients, Am J Med source
Not checked in the free run.
- Premisecitation
In 1977, Framingham investigators reported a positive association between LDL concentrations and coronary heart disease incidence.
“In 1977, Gordon and other Framingham investigators reported an inverse relationship between HDL concentrations and coronary heart disease incidence, in contrast to the positive association between LDL concentrations and coronary heart disease incidence.74”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [74] Keys, 1960, Serum cholesterol and relative body weight of coronary patients in different populations, Circulation source
Not checked in the free run.
- Premisecitation
The increased risk from weight gain was particularly apparent for heart failure.
“This risk was particularly apparent for heart failure.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [77] 1979
Not checked in the free run.
- Premisecitation
In Framingham, asymptomatic left ventricular systolic dysfunction was associated with a 5-fold increased risk of heart failure after adjustment for conventional risk factors.
“Wang and colleagues showed that individuals with asymptomatic left ventricular systolic dysfunction had a 5-fold increased risk for heart failure, even after adjusting for conventional risk factors.60”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [60] Vasan, 1997, Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction, N Engl J Med source
Not checked in the free run.
- Premisecitation
In 1977, a collaborative study reported that individuals with coronary disease had lower HDL concentrations than healthy participants across multiple ethnicities.
“That same year, in collaboration with other epidemiological studies in the United States, investigators reported that individuals with coronary disease had lower HDL concentrations than healthy participants across multiple ethnicities.75”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [75] Gordon, 1977, High density lipoprotein as a protective factor against coronary heart disease. The Framingham study, Am J Med source
Not checked in the free run.
- Premisecitation
President Nixon intervened to allow the study to continue after a planned phase-out.
“On being notified of the impending study closure by Paul Dudley White, President Richard Nixon intervened, allowing the study to continue to fulfill its mission.18”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [18] 1947
Not checked in the free run.
- Premisecitation
In Framingham, 5-year mortality after heart failure declined in men from 70% in 1950 to 59% in 1999.
“Using 50 years of follow up data, Levy and colleagues reported that the 5 year mortality declined in men from 70% in 1950 to 59% in 1999, and in women from 57% to 45%.58”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [58] Levy, 1996, The progression from hypertension to congestive heart failure, JAMA source
Not checked in the free run.
- Premisecitation
In the 1971 Framingham publication, women had a similar survival experience after heart failure diagnosis to men.
“For women, the survival experience was similar.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [56] McNamara, 1967
Not checked in the free run.
- Premisecitation
In the first half of the 20th century, autopsy and hospital-based studies noted an association between diabetes mellitus and cardiovascular disease.
“In the first half of the 20th century, autopsy and hospital-based studies had noted an association between diabetes mellitus and cardiovascular disease.63,64”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [63] Vasan, 1999, Congestive heart failure in subjects with normal versus reduced left ventricle ejection fraction: prevalence and mortality in a population-based cohort, J Am Coll Cardiol source
Not checked in the free run.
- cites [64] Root, 1939, Coronary atherosclerosis in diabetes mellitus: a postmortem study, J Am Med Assoc source
Not checked in the free run.
- Premisecitation
In 1983, Framingham investigators reported that weight gain conferred increased risk for cardiovascular disease, persisting after adjustment for other risk factors.
“In 1983, he and his colleagues reported that weight gain conferred an increased risk for cardiovascular disease, which persisted despite adjustment for other risk factors.77”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [77] 1979
Not checked in the free run.
- Premisecitation
In 1977, Framingham investigators reported an inverse relationship between HDL concentrations and coronary heart disease incidence.
“In 1977, Gordon and other Framingham investigators reported an inverse relationship between HDL concentrations and coronary heart disease incidence, in contrast to the positive association between LDL concentrations and coronary heart disease incidence.74”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [74] Keys, 1960, Serum cholesterol and relative body weight of coronary patients in different populations, Circulation source
Not checked in the free run.
- Premisecitation
In a 1978 study, Wolf et al. reported that chronic AF not due to rheumatic heart disease was associated with >5-fold excess risk of stroke.
“In a study published in 1978, Wolf and colleagues reported that chronic AF not due to rheumatic heart disease was associated with a >5-fold excess risk of stroke,79 an observation that led them to call for “controlled trials of anticoagulation or antiarrhythmic agents in persons with chronic atrial fibrillation.””
Quote in the paperSubstantial claim0 of 1 sources checked- cites [79] Kenchaiah, 2002, Obesity and the risk of heart failure, N Engl J Med source
Not checked in the free run.
- Premisecitation
A 2002 paper by Kenchaiah et al. using updated Framingham data arrived at similar conclusions about obesity and heart failure risk.
“A paper by Kenchaiah and colleagues in 2002 using updated Framingham data arrived at similar conclusions.78”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [78] Hubert, 1983, Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study, Circulation source
Not checked in the free run.
- Premisecitation
In Framingham, participants under 50 had a 2- to 3-fold excess risk of heart failure from lightest to heaviest weight category.
“Framingham participants less than 50 years old had a 2 to 3-fold excess risk of heart failure from the lightest to the heaviest weight category.77”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [77] 1979
Not checked in the free run.
- Premisecitation
Framingham data emphasized the underappreciated contribution of obesity to atrial fibrillation risk.
“Data from Framingham also emphasized the underappreciated contribution of obesity to atrial fibrillation risk.81”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [81] Benjamin, 1994, Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study, JAMA source
Not checked in the free run.
- Premisecitation
Framingham data contributed to the identification of hundreds of common genetic variants influencing cardiovascular disease risk.
“The data enabled Framingham to contribute to the global effort to study the genetic determinants of complex diseases, which has led to the identification of hundreds of common genetic variants influencing the risk of cardiovascular diseases.83”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [83] Splansky, 2007, The third generation cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: design, recruitment, and initial examination, Am J Epidemiol source
Not checked in the free run.
- Premisecitation
Benjamin et al. showed that the population attributable risk for developing atrial fibrillation was highest for hypertension, despite other risk factors having higher relative risks.
“For instance, Benjamin and colleagues showed that the PAR for developing atrial fibrillation was highest for hypertension, despite the fact that other risk factors were associated with higher relative risks.80”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [80] Wolf, 1978, Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study, Neurology source
Not checked in the free run.
- May combine two claims. 21
- Classified as probably not a substantial claim. 11
May combine two claims.
FindingcitationThe original cohort was recruited from 1948 to 1952 and included 5209 residents aged 28 to 62 years.
“The original cohort was recruited between 1948 and 1952 and consisted of 5209 residents aged 28 to 62 years (Table 1).25”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [25] Keys, 1989, Longevity of man: relative weight and fatness in middle age, Ann Med source
Not checked in the free run.
May combine two claims.
FindingcitationThe first major Framingham findings, published in 1957, defined hypertension as systolic blood pressure at least 160/95 mm Hg and found nearly a fourfold higher coronary heart disease incidence per 1000 persons among hypertensive participants.
“The first major study findings were published in 1957, almost a decade after the initial participant was examined. Defining hypertension as a systolic blood pressure ≥160/95 mmHg, they found a nearly 4 fold increase in coronary heart disease incidence per 1000 persons among hypertensive participants.26”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [26] Oppenheimer, 2006, Profiling risk: the emergence of coronary heart disease epidemiology in the United States (1947–70), Int J Epidemiol source
Not checked in the free run.
May combine two claims.
FindingcitationElevated systolic blood pressure predicted cerebrovascular accidents and heart failure, while diastolic pressure was not more strongly associated with these events.
“In two other studies, investigators found that elevated systolic blood pressure was a predictor of cerebrovascular accidents as well as heart failure, and that diastolic pressure was not superiorly associated with these events. 43,44”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [43] Kannel, 1971, Systolic versus diastolic blood pressure and risk of coronary heart disease. The Framingham study, Am J Cardiol source
Not checked in the free run.
- cites [44] Kannel, 1970, Epidemiologic assessment of the role of blood pressure in stroke. The Framingham study, JAMA source
Not checked in the free run.
May combine two claims.
FindingcitationHypertension was linked to more than a twofold heart failure risk, with population attributable risks of 59% in women and 39% in men because of its high prevalence.
“On the other hand, hypertension was associated with a >2 fold increased risk of heart failure, but had a PAR of 59% (women) and 39% (men) owing to its high prevalence.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [57] McKee, 1971, The natural history of congestive heart failure: the Framingham study, N Engl J Med source
Not checked in the free run.
May combine two claims.
FindingcitationHypertension came before three-quarters of heart failure cases, while coronary artery disease came before heart failure in fewer than 40% of cases.
“Examining 16 years of observational data, the investigators found that hypertension preceded three-quarters of heart failure cases, compared with coronary artery disease, which preceded heart failure in less than 40% of cases.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [56] McNamara, 1967
Not checked in the free run.
May combine two claims.
FindingcitationMyocardial infarction was linked to a sixfold heart failure risk, but its population attributable risk was 13% in women and 34% in men.
“Myocardial infarction was associated with a 6-fold risk for heart failure, but the PAR was only 13% (women) and 34% (men).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [57] McKee, 1971, The natural history of congestive heart failure: the Framingham study, N Engl J Med source
Not checked in the free run.
May combine two claims.
PremisecitationThe National Heart Act, signed on June 16, 1948, provided a $500,000 seed grant for a twenty-year epidemiological heart study and created the National Heart Institute.
“On June 16, 1948, President Harry Truman signed into law the ‘National Heart Act.’”
- Also stated in: § Origins of the Framingham Heart Study · plain
“The law allocated a $500,000 seed grant for a twenty-year epidemiological heart study, and also established the National Heart Institute, which today is known as the National Heart, Lung and Blood Institute.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [11] Bernstein, 1976, The uneasy alliance: Roosevelt, Churchill, and the atomic bomb, 1940–1945, West Polit Q source
Not checked in the free run.
- Also stated in: § Origins of the Framingham Heart Study · plain
Classified as probably not a substantial claim. May combine two claims.
Study design and conductcitationThe study developed clinical heart failure criteria with nine major and seven minor criteria; definite heart failure required two major criteria or one major plus two minor criteria at the same time.
“Nine ‘major’ criteria and seven ‘minor’ criteria were defined, along with one criterion that could be major or minor depending on whether the ≥4·5 Kg weight loss was due to heart failure treatment or from another possible etiology. A diagnosis of ‘Definite heart failure’ was made if the patient had two major, or one major plus two minor criteria concurrently.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [56] McNamara, 1967
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIn 1944, Roosevelt was diagnosed with hypertension, hypertensive heart disease, and cardiac failure.
“The young cardiologist gave the President his first diagnosis of “hypertension, hypertensive heart disease, and cardiac failure.”5”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [5] Bruenn, 1970, Clinical notes on the illness and death of President Franklin D. Roosevelt, Ann Intern Med source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationRoosevelt died on April 12, 1945, at age 63 from a cerebral hemorrhage, with blood pressure 300/190 mm Hg.
“President Roosevelt died a few weeks later on April 12, 1945, at the age of 63, from cerebral hemorrhage with a blood pressure of 300/190 mmHg.5”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [5] Bruenn, 1970, Clinical notes on the illness and death of President Franklin D. Roosevelt, Ann Intern Med source
Not checked in the free run.
May combine two claims.
InterpretationcitationFramingham was chosen as the study site because local physicians were enthusiastic and it was near Harvard Medical School cardiologists.
“The state was considered ideal due to the enthusiastic response of area physicians (Figure 2), and Framingham prevailed over neighboring towns due to geographical proximity to the many cardiologists at Harvard Medical School.13”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [13] Meadors, 1947
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningThe family-based cohort design was prescient given later genotyping and sequencing technologies.
“The creation of a family-based cohort was prescient, given the emergence of new genotyping and sequencing technologies a few decades later.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationThe first Framingham multivariable risk function for coronary heart disease was published by Truett, Cornfield, and Kannel in 1967 and used seven risk factors: age, total cholesterol, weight, ECG abnormality, hemoglobin, cigarettes smoked, and systolic blood pressure.
“The first attempt to create a multivariable risk function for coronary heart disease in Framingham was published by Truett, Cornfield, and Kannel in 1967.48”
- Also stated in: § Framingham Risk Scores · plain
“The authors proposed a multivariable logistic models with 7 risk factors: age, total cholesterol, weight, ECG abnormality, hemoglobin, cigarettes smoked, and systolic blood pressure.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [48] Staessen, 1997, Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension, Lancet source
Not checked in the free run.
- Also stated in: § Framingham Risk Scores · plain
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationRoosevelt's blood pressure increased from 136/78 to 188/105 mm Hg between 1935 and 1941.
“Between 1935 to 1941, the President experienced a gradual rise in blood pressure from 136/78 to 188/105 mm Hg.6 p213”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [6] Bumgarner, 1994
Not checked in the free run.
May combine two claims.
PremisecitationThe 1998 Framingham risk model used risk factor categories instead of continuous values, allowing clinicians to use lookup tables for risk estimates.
“Compared with previously published functions, the 1998 model substituted risk factor categories in the place of continuous values, which enabled clinicians to use lookup tables to obtain risk estimates.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [50] Kannel, 1976, A general cardiovascular risk profile: the Framingham study, Am J Cardiol source
Not checked in the free run.
May combine two claims.
PremisereasoningFramingham investigators initially debated whether to be observational or prevention-focused, and chose observational because effective interventions were scarce.
“Framingham investigators initially struggled between whether to be an observational study to understand heart disease, or instead focus on preventing heart disease in the local population. Ultimately, given the paucity of effective interventions, the former approach won favor.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationIn the 1940s, cardiovascular disease was the leading cause of death among Americans and accounted for about half of deaths.
“By the 1940s, cardiovascular disease had become the number one cause of mortality among Americans, accounting for 1 in 2 deaths.4”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [4] Kannel, 1990, Bishop lecture. Contribution of the Framingham study to preventive cardiology, J Am Coll Cardiol source
Not checked in the free run.
May combine two claims.
PremisecitationRandomized controlled trials showed cardiovascular benefits from lowering systolic blood pressure, leading to removal of emphasis on diastolic pressure as the main treatment target.
“The Committee still recommended diastolic blood pressure as the basis for diagnosis and treatment of hypertension, but over the next decade, the emphasis on diastolic blood pressure as the principal treatment target was dropped after randomized controlled trials demonstrated the cardiovascular benefits of systolic blood pressure reduction.46,47”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [46] Moser, 1977, Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. A cooperative study, JAMA source
Not checked in the free run.
- cites [47] 1991, Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP), JAMA source
Not checked in the free run.
May combine two claims.
PremisecitationThe population attributable risk for heart failure due to obesity was 14% in women and 11% in men, higher than for diabetes, valvular heart disease, or left ventricular hypertrophy.
“The PAR for heart failure due to obesity was 14% in women, and 11% in men, higher than that observed for diabetes mellitus, valvular heart disease, or left ventricular hypertrophy.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [78] Hubert, 1983, Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study, Circulation source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationRecent guidelines emphasize detection of asymptomatic ventricular dysfunction (stage B heart failure) to understand and prevent overt heart failure.
“Recent guidelines have a notable emphasis on the detection of asymptomatic ventricular dysfunction (“stage B heart failure”) as part of efforts to understand and prevent overt heart failure.61”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [61] Wang, 2003, Natural history of asymptomatic left ventricular systolic dysfunction in the community, Circulation source
Not checked in the free run.
May combine two claims.
PremisecitationIn the 1971 Framingham publication, 5-year survival after heart failure diagnosis was 2 in 5 men, and 10-year survival was 1 in 5 men.
“The original 1971 publication highlighted the poor prognosis of heart failure: only 2 in 5 men were alive 5 years after diagnosis the heart failure, and only 1 in 5 survived to 10 years.56”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [56] McNamara, 1967
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationBy the late 1970s, the general US population weight had been increasing for several decades.
“By the late 1970s, when William Castelli became the fourth director of the Framingham Heart Study, the general US population weight had been increasing for several decades.76”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [76] Castelli, 1977, HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study, Circulation source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAncel Keys described elevated cholesterol levels among coronary heart disease patients.
“Ancel Keys described elevated levels of cholesterol among coronary heart disease patients.73”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [73] Anitschkow, 1983, Classics in arteriosclerosis research: on experimental cholesterin steatosis and its significance in the origin of some pathological processes, Arteriosclerosis
Not checked in the free run.
May combine two claims.
PremisecitationThe 1976 risk profile variables matched the Truett study except that glucose intolerance was added and weight was removed.
“The variables in the model mirrored those in the Truett study, except that glucose intolerance was added, and weight was dropped.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [49] Truett, 1967, A multivariate analysis of the risk of coronary heart disease in Framingham, J Chronic Dis source
Not checked in the free run.
May combine two claims.
PremisecitationDiabetes was associated with substantially higher risks for heart failure and hypertensive heart disease.
“Diabetes was associated with substantially higher risks for heart failure and hypertensive heart disease.69,70”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [69] Garcia, 1974, Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study, Diabetes source
Not checked in the free run.
- cites [70] Kannel, 1974, Role of diabetes in congestive heart failure: the Framingham study, Am J Cardiol source
Not checked in the free run.
May combine two claims.
PremisecitationSurvival of individuals with heart failure with preserved ejection fraction was substantially worse than those without heart failure, but better than those with systolic heart failure.
“Survival of individuals with heart failure with preserved ejection fraction (or diastolic heart failure) was substantially worse compared with individuals without heart failure, though it was better compared with individuals with systolic heart failure.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [62] Hunt, 2005, Circulation source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationCholesterol had been linked to cardiovascular disease by the early 20th century through animal and autopsy studies.
“Cholesterol had been linked to cardiovascular disease by the early 20th century through animal and autopsy studies.71,72”
Quote in the paperNot a substantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationCritics questioned whether Framingham participants represented Americans generally and criticized the family-based approach.
“Critics of Framingham expressed uncertainty about whether study participants represented Americans in general and about the study's family-based approach.33”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [33] Caird, 1963, Heart disease in old age, Postgrad Med J source
Not checked in the free run.
The paper relies on this without support.
By the 1990s, widespread use of beta-blockers and ACE inhibitors altered the prognosis of heart failure.
“By the 1990s, the widespread use of mortality-altering medications such as beta-blockers and ACE inhibitors had altered this prognosis.”
The paper relies on this without support.
Diastolic heart failure is common in the community, particularly among older individuals and women.
“Studies from other cohorts yielded consistent findings, and led to increased recognition that diastolic heart failure is common in the community, particularly among older individuals and women.”
The paper relies on this without support.
Obesity co-occurs with hypertension, elevated lipids, and diabetes, and increased cardiovascular risk in obese individuals is often attributed to these co-existing risk factors.
“As obesity occurs concomitantly with hypertension, elevated lipids, and diabetes, the increased cardiovascular risk in obese individuals is often attributed to these co-existing risk factors.”
The paper relies on this without support.
Each suspected new case of stroke in Framingham was confirmed by a second examiner and through neurological consultation.
“Each suspected new case of stroke was confirmed by a second examiner as well as through neurological consultation.”
The paper relies on this without support.
Anticoagulation for individuals with atrial fibrillation became the standard of care.
“Fortunately, such trials were performed and anticoagulation for individuals with atrial fibrillation became the standard of care.”
The paper relies on this without support.
Heart failure diagnoses in Framingham have been prospectively adjudicated using a single set of diagnostic criteria since the 1960s.
“Because heart failure diagnoses in Framingham have been prospectively adjudicated using a single set of diagnostic criteria since the 1960s, the study has been a valuable source of information regarding long-term trends in the epidemiology of the condition.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The Framingham Heart Study has demonstrated that hypertension, coronary artery disease, cardiac hypertension and diabetes are cardiovascular risk factors associated with the future development of heart failure.
“Over its 74-year length, the Framingham Heart Study has demonstrated that hypertension, coronary artery disease, cardiac hypertension and diabetes are cardiovascular risk factors associated with the future development of heart failure [2,3].”
From Recent Experimental Studies of Maternal Obesity, Diabetes during Pregnancy and the Developmental Origins of Cardiovascular Disease (2022) · cites this paper as [2]
The sections on heart-failure epidemiology and metabolic risk factors report that hypertension and coronary artery disease preceded heart failure, and that diabetes was associated with substantially higher heart-failure risk. The paper does not identify “cardiac hypertension” as a separate risk factor; it mentions hypertensive heart disease as an outcome associated with diabetes. (LLM, conf=0.88)
Experimental — accuracy not yet measuredBiobank efforts pioneered in Framingham and DeCODE now encompass a growing inventory of national cohorts in North America, Europe, Asia and beyond.
“These biobank efforts, pioneered in studies such as the Framingham Cohort70 and the efforts of DeCODE in Iceland71,72, now encompass a growing inventory of national cohorts in North America, Europe, Asia and beyond73–76.”
From A brief history of human disease genetics (2020) · cites this paper as [70]
The iAge gene expression signature was significantly associated with all-cause mortality in the Framingham Heart Study after adjustment for multiple mortality-related covariates.
“We observed that the iAge gene signature was significantly associated with all-cause mortality following adjustment to multiple covariates associated with mortality, including age, sex, smoking, cholesterol levels, blood pressure, diabetes and existence of a cardiovascular disease (P = 0.02, Cox proportional hazards model, n = 2,290).”
From An inflammatory aging clock (iAge) based on deep learning tracks multimorbidity, immunosenescence, frailty and cardiovascular aging (2021) · cites this paper as [36]
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944 · see citing works
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070 · see citing works
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581 · see citing works
Self-citationHeart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Beaton, A. Z., Boehme, A. K., Buxton, A. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001123 · Cited by 8,300 · see citing works
Heart Disease and Stroke Statistics—2013 Update: A Report From the American Heart Association
Go, A. S., Mozaffarian, D., Roger, V. L., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., Fox, C. S., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31828124ad · Cited by 5,292 · see citing works
High density lipoprotein as a protective factor against coronary heart disease
Gordon, T., Castelli, W. P., Hjortland, M. C., Kannel, W. B., & Dawber, T. R. (1977) · The American Journal of Medicine · doi:10.1016/0002-9343(77)90874-9 · Cited by 5,059 · see citing works
Hubert, H. B., Feinleib, M., McNamara, P. M., & Castelli, W. P. (1983) · Circulation · doi:10.1161/01.cir.67.5.968 · Cited by 4,241 · see citing works
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
Hunt, S. A. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.08.022 · Cited by 4,127 · see citing works
The natural history of congestive heart failure: the Framingham study
McKee, P. A., Castelli, W. P., McNamara, P. M., & Kannel, W. B. (1971) · New England Journal of Medicine · doi:10.1056/nejm197112232852601 · Cited by 3,448 · see citing works
Obesity and the risk of heart failure
Kenchaiah, S., Evans, J. C., Levy, D., Wilson, P. W. F., Benjamin, E. J., Larson, M. G., Kannel, W. B., & Vasan, R. S. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020245 · Cited by 3,093 · see citing works
Self-citationStaessen, J. A., Fagard, R., Thijs, L., Celis, H., Arabidze, G. G., Birkenhäger, W. H., Bulpitt, C. J., de Leeuw, P. W., Dollery, C. T., Fletcher, A. E., et al. (1997) · The Lancet · doi:10.1016/s0140-6736(97)05381-6 · Cited by 2,989 · see citing works
Benjamin, E. J. (1994) · JAMA · doi:10.1001/jama.1994.03510350050036 · Cited by 2,613 · see citing works
WRITING COMMITTEE MEMBERS, Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.167586 · Cited by 2,251 · see citing works
The progression from hypertension to congestive heart failure
Levy, D. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03530440037034 · Cited by 2,155 · see citing works
Self-citationLong-term trends in the incidence of and survival with heart failure
Levy, D., Kenchaiah, S., Larson, M. G., Benjamin, E. J., Kupka, M. J., Ho, K. K. L., Murabito, J. M., & Vasan, R. S. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020265 · Cited by 2,152 · see citing works
Self-citationEpidemiological approaches to heart disease: the Framingham study
Dawber, T. R., Meadors, G. F., & Moore, F. E. (1951) · American Journal of Public Health and the Nations Health · doi:10.2105/ajph.41.3.279 · Cited by 2,148 · see citing works
Role of diabetes in congestive heart failure: The Framingham study
Kannel, W. B., Hjortland, M., & Castelli, W. P. (1974) · The American Journal of Cardiology · doi:10.1016/0002-9149(74)90089-7 · Cited by 2,090 · see citing works
Dawber, T. R. (1980) · Harvard University Press eBooks · doi:10.4159/harvard.9780674492097 · Cited by 1,962 · see citing works
KANNEL, W. B., DAWBER, T. R., KAGAN, A., REVOTSKIE, N., & STOKES, J. (1961) · Annals of Internal Medicine · doi:10.7326/0003-4819-55-1-33 · Cited by 1,837 · see citing works
AN INVESTIGATION OF CORONARY HEART DISEASE IN FAMILIES
Kannel, W. B., Feinleib, M., McNAMARA, P. M., Garrison, R. J., & Castelli, W. P. (1979) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112813 · Cited by 1,635 · see citing works
Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study
Garcia, M. J., McNamara, P. M., Gordon, T., & Kannell, W. B. (1974) · Diabetes · doi:10.2337/diab.23.2.105 · Cited by 1,608 · see citing works
Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The fiamingham Study
Wolf, P. A., Dawber, T. R., Thomas, H. E., & Kannel, W. B. (1978) · Neurology · doi:10.1212/wnl.28.10.973 · Cited by 1,526 · see citing works
Castelli, W. P., Doyle, J. T., Gordon, T., Hames, C. G., Hjortland, M. C., Hulley, S. B., Kagan, A., & Zukel, W. J. (1977) · Circulation · doi:10.1161/01.cir.55.5.767 · Cited by 1,492 · see citing works
Obesity and the risk of new-onset atrial fibrillation
Wang, T. J. (2004) · JAMA · doi:10.1001/jama.292.20.2471 · Cited by 1,427 · see citing works
Self-citationCongestive heart failure in subjects with normal versus reduced left ventricular ejection fraction
Vasan, R. S., Larson, S., Benjamin, E. J., Evans, J. C., Reiss, C. K., & Levy, D. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00118-7 · Cited by 1,331 · see citing works
Self-citationDiabetes and cardiovascular risk factors: the Framingham study
Kannel, W. B., & McGee, D. L. (1979) · Circulation · doi:10.1161/01.cir.59.1.8 · Cited by 1,317 · see citing works
PRINCIPLES OF INTERNAL MEDICINE
HARRISON, T. R., Adams, R. D., Beeson, P. B., Resnik, W. H., Thorn, G. W., & Wintrobe, M. M. (1955) · The American Journal of the Medical Sciences · doi:10.1097/00000441-195507000-00024 · Cited by 1,293 · see citing works
A general cardiovascular risk profile: The Framingham study
Kannel, W. B., McGee, D., & Gordon, T. (1976) · The American Journal of Cardiology · doi:10.1016/0002-9149(76)90061-8 · Cited by 1,189 · see citing works
A multivariate analysis of the risk of coronary heart disease in Framingham
Truett, J., Cornfield, J., & Kannel, W. (1967) · Journal of Chronic Diseases · doi:10.1016/0021-9681(67)90082-3 · Cited by 958 · see citing works
Systolic versus diastolic blood pressure and risk of coronary heart disease
Kannel, W. B., Gordon, T., & Schwartz, M. J. (1971) · The American Journal of Cardiology · doi:10.1016/0002-9149(71)90428-0 · Cited by 925 · see citing works
Clinical features of sudden obstruction of the coronary arteries
HERRICK, J. B. (1912) · Journal of the American Medical Association · doi:10.1001/jama.1912.04270120001001 · Cited by 908 · see citing works
Splansky, G. L., Corey, D., Yang, Q., Atwood, L. D., Cupples, L. A., Benjamin, E. J., D'Agostino, R. B., Fox, C. S., Larson, M. G., Murabito, J. M., et al. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm021 · Cited by 860 · see citing works
Self-citationThe Framingham Offspring Study
Allhoff, P., Laaser, U., & Heinrich, J. (1991) · Springer eBooks · doi:10.1007/978-3-642-95642-3_25 · Cited by 832 · see citing works
II. Coronary Heart Disease in the Framingham Study
Dawber, T. R., Moore, F. E., & Mann, G. V. (1957) · American Journal of Public Health and the Nations Health · doi:10.2105/ajph.47.4_pt_2.4 · Cited by 718 · see citing works
Epidemiologic assessment of the role of blood pressure in stroke. The Framingham study
Kannel, W. B. (1970) · JAMA · doi:10.1001/jama.214.2.301 · Cited by 706 · see citing works
Natural history of asymptomatic left ventricular systolic dysfunction in the community
Wang, T. J., Evans, J. C., Benjamin, E. J., Levy, D., LeRoy, E. C., & Vasan, R. S. (2003) · Circulation · doi:10.1161/01.cir.0000085166.44904.79 · Cited by 633 · see citing works
Self-citationRole of Blood Pressure in the Development of Congestive Heart Failure: The Framingham Study
Kannel, W. B., Castelli, W. P., McNamara, P. M., McKee, P. A., & Feinleib, M. (1972) · New England Journal of Medicine · doi:10.1056/nejm197210192871601 · Cited by 603 · see citing works
Use of Propranolol (Inderal) in Treatment of Hypertension
Prichard, B. N. C., & Gillam, P. M. C. (1964) · BMJ · doi:10.1136/bmj.2.5411.725 · Cited by 417 · see citing works
Krishan, I. (1977) · Journal of Occupational and Environmental Medicine · doi:10.1097/00043764-197704000-00083 · Cited by 402 · see citing works
Vasan, R. S., Larson, M. G., Benjamin, E. J., Evans, J. C., & Levy, D. (1997) · New England Journal of Medicine · doi:10.1056/nejm199705083361903 · Cited by 402 · see citing works
Self-citationVariants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry
Benjamin, E. J., Rice, K. M., Arking, D. E., Pfeufer, A., van Noord, C., Smith, A. V., Schnabel, R. B., Bis, J. C., Boerwinkle, E., Sinner, M. F., et al. (2009) · Nature Genetics · doi:10.1038/ng.416 · Cited by 390 · see citing works
Self-citationCecil-Loeb Textbook of Medicine.
(1971) · Annals of Internal Medicine · doi:10.7326/0003-4819-75-5-813 · Cited by 341 · see citing works
(1977) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1977.03270300059008 · Cited by 334 · see citing works
Hunt, S. (2005) · Medical Entomology and Zoology · Cited by 280 · see citing works
Fifty years of Framingham Study contributions to understanding hypertension
Kannel, W. B. (2000) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1000949 · Cited by 263 · see citing works
Vascular Disease of the Brain—Epidemiologic Aspects: The Framingham Study
Kannel, W. B., Dawber, T. R., Pm, M., & Cohen, M. E. (1965) · American Journal of Public Health and the Nations Health · doi:10.2105/ajph.55.9.1355 · Cited by 210 · see citing works
Blood-sugar and arterial disease
Keen, H., Rose, G., Pyke, D. A., Boyns, D., Chlouverakis, C., & Mistry, S. (1965) · The Lancet · doi:10.1016/s0140-6736(65)91470-4 · Cited by 180 · see citing works
Acute Myocardial Infarction in 258 Cases of Diabetes
Partamian, J. O., & Bradley, R. F. (1965) · New England Journal of Medicine · doi:10.1056/nejm196508262730901 · Cited by 162 · see citing works
Contribution of the framingham study to preventive cardiology
Kannel, W. B. (1990) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(90)90203-2 · Cited by 149 · see citing works
Chapman, J. M., Goerke, L. S., Dixon, W., Loveland, D. B., & Phillips, E. (1957) · American Journal of Public Health and the Nations Health · doi:10.2105/ajph.47.4_pt_2.33 · Cited by 133 · see citing works
The European Health Report 2012: Charting the Way to Well-being
Regional Office for Europe (2013) · Cited by 130 · see citing works
Principles of Internal Medicine
Durant, T. M. (1966) · JAMA · doi:10.1001/jama.1966.03110180109042 · Cited by 114 · see citing works
(1983) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.3.2.178 · Cited by 101 · see citing works
Epidemiologic Assessment of the Role of Blood Pressure in Stroke
Lassen, N. A. (1996) · JAMA · doi:10.1001/jama.1996.03540150081041 · Cited by 99 · see citing works
CORONARY ATHEROSCLEROSIS IN DIABETES MELLITUS: A POSTMORTEM STUDY
ROOT, H. F., BLAND, E. F., GORDON, W. H., & WHITE, P. D. (1939) · Journal of the American Medical Association · doi:10.1001/jama.1939.02800260029008 · Cited by 98 · see citing works
Arteriosclerotic heart disease in diabetes mellitus
Liebow, I. M., Hellerstein, H. K., & Miller, M. (1955) · The American Journal of Medicine · doi:10.1016/0002-9343(55)90224-2 · Cited by 94 · see citing works
Weight by height and age for adults 18-74 years. United States, 1971-74.
Abraham, S., Johnson, C. L., & Najjar, M. F. (1979) · PubMed · Cited by 87 · see citing works
Clinical notes on the illness and death of President Franklin D. Roosevelt
BRUENN, H. G. (1970) · Annals of Internal Medicine · doi:10.7326/0003-4819-72-4-579 · Cited by 84 · see citing works
Systolic hypertension: A pathogenetic entity
GUBNER, R. S. (1962) · The American Journal of Cardiology · doi:10.1016/0002-9149(62)90139-x · Cited by 75 · see citing works
Serum cholesterol and relative body weight of coronary patients in different populations
KEYS, A., & FIDANZA, F. (1960) · Circulation · doi:10.1161/01.cir.22.6.1091 · Cited by 74 · see citing works
Risk factors and coronary heart disease—facts or fancy?
Werkö, L. (1976) · American Heart Journal · doi:10.1016/s0002-8703(76)80439-5 · Cited by 73 · see citing works
Anitschkow, N. (1983) · Arteriosclerosis An Official Journal of the American Heart Association Inc · Cited by 67 · see citing works
Weight and height of adults 18-74 years of age. United States, 1971-74.
Abraham, S., Johnson, C. L., & Najjar, M. F. (1979) · PubMed · Cited by 66 · see citing works
The prevalence of congestive heart failure in two rural communities
Gibson, T. C., White, K. L., & Klainer, L. M. (1966) · Journal of Chronic Diseases · doi:10.1016/0021-9681(66)90045-2 · Cited by 65 · see citing works
Profiling risk: the emergence of coronary heart disease epidemiology in the United States (1947–70)
Oppenheimer, G. M. (2006) · International Journal of Epidemiology · doi:10.1093/ije/dyl014 · Cited by 62 · see citing works
Cardiac complications of diabetes mellitus
Liebow, I. M., & Hellerstein, H. K. (1949) · The American Journal of Medicine · doi:10.1016/0002-9343(49)90388-5 · Cited by 47 · see citing works
Waterston, D., Orr, J., & Cappell, D. F. (1939) · Heart · doi:10.1136/hrt.1.3.237 · Cited by 33 · see citing works
Longevity of man: relative weight and fatness in middle age
Keys, A. (1989) · Annals of Medicine · doi:10.3109/07853898909149927 · Cited by 31 · see citing works
Caird, F. I. (1963) · Postgraduate Medical Journal · doi:10.1136/pgmj.39.453.408 · Cited by 29 · see citing works
Finenberg (1927) · doi:10.1097/00000441-192706000-00010 · Cited by 29 · see citing works
Levy, D. A., & Brink, S. G. (2005) · Cited by 27 · see citing works
Self-citationThe uneasy alliance: Roosevelt, Churchill, and the atomic bomb, 1940–1945
Bernstein, B. J. (1976) · The Western Political Quarterly · doi:10.2307/448105 · Cited by 27 · see citing works
Churchill: Taken from the Diaries of Lord Moran: The Struggle for Survival, 1940-1965
Moran, C. M. W. (2017) · The SHAFR Guide Online · doi:10.1163/2468-1733_shafr_sim130020069 · Cited by 23 · see citing works
Warren, B. (2005) · Baylor University Medical Center Proceedings · doi:10.1080/08998280.2005.11928110 · Cited by 22 · see citing works
The Uneasy Alliance: Roosevelt, Churchill, and the Atomic Bomb, 1940-1945
Bernstein, B. J. (1976) · The Western Political Quarterly · doi:10.1177/106591297602900208 · Cited by 18 · see citing works
Heart failure in hypertensive patients
Mickerson, J. N. (1963) · American Heart Journal · doi:10.1016/0002-8703(63)90161-3 · Cited by 18 · see citing works
Yang, B. K. (2005) · PubMed · Cited by 13 · see citing works
Churchill Taken From the Diaries of Lord Moran: The Struggle for Survival.
Aring, C. D. (1967) · Archives of Internal Medicine · doi:10.1001/archinte.1967.00300010121027 · Cited by 11 · see citing works
History of the Council on Epidemiology and Prevention, American Heart Association
BLACKBURN, H. W., & Epstein, F. H. (1995) · Circulation · doi:10.1161/01.cir.91.4.1253 · Cited by 6 · see citing works
Oransky, I. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17578-8 · Cited by 6 · see citing works
ETIOLOGY OF CONGESTIVE HEART FAILUREIN CLINICAL MEDICINE
Benack, R. T. (1969) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1969.tb16754.x · Cited by 5 · see citing works
Oransky, I. (2006) · The Lancet · doi:10.1016/s0140-6736(06)67950-6 · Cited by 3 · see citing works
Epidemiologic Assessment of the Role of Blood Pressure in Stroke: The Framingham Study
Kannel, W. B. (1970) · JAMA · doi:10.1001/jama.1970.03180020021004 · Cited by 2 · see citing works
Flagged first, then by citations
1 of the 86 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- 1948, 80th US Congress, 2nd Session, Senate Report 2215, The National Heart Act, 481, 62
- Keys, 1960, Serum cholesterol and relative body weight of coronary patients in different populations, Circulation, 22, 1091, 10.1161/01.cir.22.6.1091 · DOI · Paper page
Cited by
Sorted by citations
Opportunities and obstacles for deep learning in biology and medicine
Ching, T., Himmelstein, D. S., Beaulieu-Jones, B. K., Kalinin, A. A., Do, B. T., Way, G. P., Ferrero, E., Agapow, P.-M., Zietz, M., Hoffman, M. M., et al. (2018) · Journal of The Royal Society Interface · doi:10.1098/rsif.2017.0387 · Cited by 2,310 · see citing works
Effects of stress on the development and progression of cardiovascular disease
Kivimäki, M., & Steptoe, A. (2018) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.189 · Cited by 1,197 · see citing works
European Society of Cardiology: cardiovascular disease statistics 2021
Timmis, A., Vardas, P. E., Townsend, N. P., Torbica, A., Katus, H. A., Smedt, D. D., Gale, C. P., Maggioni, A. P., Petersen, S. E., Huculeci, R., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab892 · Cited by 1,166 · see citing works
European Society of Cardiology: Cardiovascular Disease Statistics 2019
Timmis, A., Townsend, N. P., Gale, C. P., Torbica, A., Lettino, M., Petersen, S. E., Mossialos, E. A., Maggioni, A. P., Kazakiewicz, D., May, H. T., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz859 · Cited by 1,035 · see citing works
European Society of Cardiology: Cardiovascular Disease Statistics 2017
Timmis, A., Petersen, S. E., Belle, E. V., Townsend, N. P., Conrad, N., Kaplon-Cieslicka, A., Kazakiewicz, D., Kavousi, M., Cvijić, M., Ignatiuk, B., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehag345 · Cited by 964 · see citing works
Interpretation and Impact of Real-World Clinical Data for the Practicing Clinician
Blonde, L., Khunti, K. K., Harris, S. B., Meizinger, C., & SKOLNIK, N. (2018) · Advances in Therapy · doi:10.1007/s12325-018-0805-y · Cited by 734 · see citing works
Risk factors for coronary artery disease: Historical perspectives
Hajar, R. (2017) · Heart Views · doi:10.4103/heartviews.heartviews_106_17 · Cited by 715 · see citing works
A brief history of human disease genetics
Claussnitzer, M., Cho, J. H., Collins, R., Cox, N. J., Dermitzakis, E. T., Hurles, M. E., Kathiresan, S., Kenny, E. E., Lindgren, C. M., MacArthur, D. G., et al. (2020) · Nature · doi:10.1038/s41586-019-1879-7 · Cited by 697 · see citing works
Sayed, N., Huang, Y., Nguyen, K., Krejciova-Rajaniemi, Z., Grawe, A. P., Gao, T., Tibshirani, R., Hastie, T., Alpert, A., Cui, L., et al. (2021) · Nature Aging · doi:10.1038/s43587-021-00082-y · Cited by 572 · see citing works
Human genetic variation and the gut microbiome in disease
Hall, A. B., Tolonen, A. C., & Xavier, R. J. (2017) · Nature Reviews Genetics · doi:10.1038/nrg.2017.63 · Cited by 517 · see citing works
O’Sullivan, J. W., Raghavan, S., Márquez‐Luna, C., Luzum, J. A., Damrauer, S. M., Ashley, E. A., O’Donnell, C. J., Willer, C. J., & Natarajan, P. (2022) · Circulation · doi:10.1161/cir.0000000000001077 · Cited by 424 · see citing works
Multimodal deep learning for Alzheimer's disease dementia assessment
Qiu, S., Miller, M. I., Joshi, P. S., Lee, J. C., Xue, C., Ni, Y., Wang, Y., De Anda-Duran, I., Hwang, P. H., Cramer, J. A., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31037-5 · Cited by 420 · see citing works
Insulin resistance and cardiovascular disease
Kosmas, C. E., Bousvarou, M. D., Kostara, C. E., Papakonstantinou, E. J., Salamou, E., & Guzman, E. (2023) · Journal of International Medical Research · doi:10.1177/03000605231164548 · Cited by 413 · see citing works
Atrial Fibrillation: Pathogenesis, Predisposing Factors, and Genetics
Sagris, Μ., Vardas, E. P., Theofilis, P., Antonopoulos, A. S., Oikonomou, E. K., & Tousoulis, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010006 · Cited by 408 · see citing works
Alterations in the gut microbiome and metabolism with coronary artery disease severity
Liu, H., Chen, X., Hu, X., Niu, H., Tian, R., Wang, H., Pang, H., Jiang, L., Qiu, B., Chen, X., et al. (2019) · Microbiome · doi:10.1186/s40168-019-0683-9 · Cited by 374 · see citing works
Axes of a revolution: challenges and promises of big data in healthcare
Shilo, S., Rossman, H., & Segal, E. (2020) · Nature Medicine · doi:10.1038/s41591-019-0727-5 · Cited by 370 · see citing works
Association of risk factors with type 2 diabetes: A systematic review
Ismail, L., Materwala, H., & Alkaabi, J. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.03.003 · Cited by 366 · see citing works
Maslove, D. M., Tang, B. M. P., Shankar‐Hari, M., Lawler, P. R., Angus, D. C., Baillie, J. K., Baron, R. M., Bauer, M. W., Buchman, T. G., Calfee, C. S., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01843-x · Cited by 365 · see citing works
European Society of Cardiology: the 2023 Atlas of Cardiovascular Disease Statistics
Timmis, A., Aboyans, V., Vardas, P. E., Townsend, N. P., Torbica, A., Kavousi, M., Boriani, G., Huculeci, R., Kazakiewicz, D., Scherr, D., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae466 · Cited by 337 · see citing works
70-year legacy of the Framingham Heart Study
Andersson, C., Johnson, A. D., Benjamin, E. J., Levy, D., & Vasan, R. S. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0202-5 · Cited by 305 · see citing works
Self-citationLatic, N., & Erben, R. G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186483 · Cited by 302 · see citing works
Scott, A. J., Alexander, J. L., Merrifield, C. A., Cunningham, D., Jobin, C., Brown, R., Alverdy, J., O’Keefe, S. J., Gaskins, H. R., Teare, J., et al. (2019) · Gut · doi:10.1136/gutjnl-2019-318556 · Cited by 288 · see citing works
UK Biobank: Opportunities for cardiovascular research
Littlejohns, T. J., Sudlow, C., Allen, N. E., & Collins, R. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehx254 · Cited by 270 · see citing works
Andreassen, O. A., Hindley, G., Frei, O., & Smeland, O. B. (2023) · World Psychiatry · doi:10.1002/wps.21034 · Cited by 255 · see citing works
Comorbidities in clinical practice. Algorithms for diagnostics and treatment
Гегамович, О. Р., Simanenkov, V. I., Бакулин, И. Г., Бакулина, Н. В., Барбараш, О. Л., Boytsov, S. A., Афанасьевна, Б. С., Garganeeva, N. P., Doshchitsin, V. L., Karateev, A. E., et al. (2019) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2019-1-5-66 · Cited by 250 · see citing works
Epidemiology of Coronary Artery Disease
Duggan, J. P., Peters, A. S., Trachiotis, G. D., & Antevil, J. L. (2022) · Surgical Clinics of North America · doi:10.1016/j.suc.2022.01.007 · Cited by 245 · see citing works
Heme Oxygenases in Cardiovascular Health and Disease
Ayer, A., Zarjou, A., Agarwal, A., & Stocker, R. (2016) · Physiological Reviews · doi:10.1152/physrev.00003.2016 · Cited by 243 · see citing works
Alkhodari, M., & Fraiwan, L. (2021) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2021.105940 · Cited by 236 · see citing works
Hypertension as a risk factor for atherosclerosis: Cardiovascular risk assessment
Poznyak, A. V., Sadykhov, N. K., Kartuesov, A. G., Borisov, E. E., Melnichenko, A. А., Grechko, A. V., & Orekhov, A. N. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.959285 · Cited by 229 · see citing works
Foote, C. A., Soares, R. N., Ramirez‐Perez, F. I., Ghiarone, T., Aroor, A. R., Manrique‐Acevedo, C., Padilla, J., & Martinez‐Lemus, L. A. (2022) · Comprehensive physiology · doi:10.1002/cphy.c210029 · Cited by 226 · see citing works
Arterial structure and function in vascular ageing: are you as old as your arteries?
Thijssen, D. H. J., Carter, S. E., & GREEN, D. J. (2015) · The Journal of Physiology · doi:10.1113/jp270597 · Cited by 218 · see citing works
The Importance of Gender to Understand Sex Differences in Cardiovascular Disease
Connelly, P. J., Azizi, Z., Alipour, P., Delles, C., Pilote, L., & Raparelli, V. (2021) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2021.02.005 · Cited by 194 · see citing works
Network Medicine in the Age of Biomedical Big Data
Sonawane, A. R., Weiss, S. T., Glass, K., & Sharma, A. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00294 · Cited by 189 · see citing works
Comorbidity associated with obesity in a large population: The APNA study.
Rodríguez, E. M., Guillén-Grima, F., Martí, A., & Brugos-Larumbe, A. (2015) · Obesity Research and Clinical Practice · doi:10.1016/j.orcp.2015.04.003 · Cited by 187 · see citing works
Chiva‐Blanch, G., & Badimón, L. (2019) · Nutrients · doi:10.3390/nu12010108 · Cited by 188 · see citing works
Variability of risk factors and diabetes complications
Ceriello, A., & Prattichizzo, F. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01289-4 · Cited by 186 · see citing works
Avan, A., Tavakoly Sany, S. B., Ghayour‐Mobarhan, M., Rahimi, H. R., Tajfard, M., & Ferns, G. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26791 · Cited by 182 · see citing works
Data Integration Challenges for Machine Learning in Precision Medicine
Martínez-García, M., & Hernández-Lemus, E. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.784455 · Cited by 158 · see citing works
Endogenous oxidized phospholipids reprogram cellular metabolism and boost hyperinflammation
Gioia, M. D., Spreafico, R., Springstead, J. R., Mendelson, M., Joehanes, R., Levy, D. A., & Zanoni, I. (2019) · Nature Immunology · doi:10.1038/s41590-019-0539-2 · Cited by 174 · see citing works
Self-citationHow far from the SNP may the causative genes be?
Brodie, A., Azaria, J. R., & Ofran, Y. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw500 · Cited by 172 · see citing works
Artificial Intelligence and Early Detection of Pancreatic Cancer: 2020 Summative Review
Kenner, B., Chari, S. T., Kelsen, D., Klimstra, D. S., Pandol, S. J., Rosenthal, M., Rustgi, A. K., Taylor, J. A., Yala, A., Abul-Husn, N., et al. (2021) · Pancreas · doi:10.1097/mpa.0000000000001762 · Cited by 158 · see citing works
Palmer, M. K., & Toth, P. P. (2019) · Obesity · doi:10.1002/oby.22370 · Cited by 156 · see citing works
Mezzatesta, S., Torino, C., Meo, P. D., Fiumara, G., & Vilasi, A. D. (2019) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2019.05.005 · Cited by 151 · see citing works
The Pathophysiology of Myocardial Ischemia and Perioperative Myocardial Infarction
Smit, M., Coetzee, A., & Lochner, A. (2019) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2019.10.005 · Cited by 148 · see citing works
Hernando‐Amado, S., Coque, T. M., Baquero, F., & Martínez, J. L. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01914 · Cited by 141 · see citing works
Li, Y., Sperrin, M., Ashcroft, D. M., & van Staa, T. P. (2020) · BMJ · doi:10.1136/bmj.m3919 · Cited by 141 · see citing works
Su, J., Li, Z., Huang, M., Wang, Y., Yang, T., Ma, M., Ni, T., Pan, G., Lai, Z., Li, C., et al. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01523-7 · Cited by 137 · see citing works
Jordan, D. M., Choi, H. K., Verbanck, M., Topless, R., Won, H., Nadkarni, G. N., Merriman, T. R., & Do, R. (2019) · PLoS Medicine · doi:10.1371/journal.pmed.1002725 · Cited by 136 · see citing works
The future of precision medicine: potential impacts for health technology assessment
Love-Koh, J., Peel, A., Rejon-Parrilla, J. C., Ennis, K., Lovett, R., Manca, A., Chalkidou, A., Wood, H., & Taylor, M. (2018) · PharmacoEconomics · doi:10.1007/s40273-018-0686-6 · Cited by 131 · see citing works
Framingham contribution to cardiovascular disease
Hajar, R. (2016) · Heart Views · doi:10.4103/1995-705x.185130 · Cited by 127 · see citing works
Associations of loneliness with risk of Alzheimer's disease dementia in the Framingham Heart Study
Akhter‐Khan, S. C., Tao, Q., Ang, T. F. A., Itchapurapu, I. S., Alosco, M. L., Mez, J., Piers, R. J., Steffens, D. C., Au, R., & Qiu, W. Q. (2021) · Alzheimer's & Dementia · doi:10.1002/alz.12327 · Cited by 126 · see citing works
Incidence of Major Cardiovascular Events in Immigrants to Ontario, Canada
Tu, J. V., Chu, A., Rezai, M. R., Guo, H., Maclagan, L. C., Austin, P. C., Booth, G. L., Manuel, D. G., Chiu, M., Ko, D. T., et al. (2015) · Circulation · doi:10.1161/circulationaha.115.015345 · Cited by 126 · see citing works
Prevalence and Risk Factors of Metabolic Syndrome: A Prospective Study on Cardiovascular Health
Rus, M., Crișan, S., Andronie-Cioară, F. L., Indries, M. F., Marian, P., Pobirci, O. L., & Ardelean, A. I. (2023) · Medicina · doi:10.3390/medicina59101711 · Cited by 125 · see citing works
The Role of Matrix Gla Protein (MGP) in Vascular Calcification
Bjørklund, G., Svanberg, E., Dadar, M., Card, D. J., Chirumbolo, S., Harrington, D. J., & Aaseth, J. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867325666180716104159 · Cited by 123 · see citing works
Cai, Y., Cai, Y.-Q., Tang, L.-Y., Wang, Y.-H., Gong, M., Jing, T.-C., Li, H.-J., Li-Ling, J., Hu, W., Yin, Z., et al. (2024) · BMC Medicine · doi:10.1186/s12916-024-03273-7 · Cited by 122 · see citing works
Using Electronic Health Records To Generate Phenotypes For Research
Pendergrass, S. A., & Crawford, D. C. (2019) · Current Protocols in Human Genetics · doi:10.1002/cphg.80 · Cited by 120 · see citing works
Dynamic Role of trans Regulation of Gene Expression in Relation to Complex Traits
Yao, C., Joehanes, R., Johnson, A. D., Huan, T., Liu, C., Freedman, J. E., Munson, P. J., Hill, D. E., Vidal, M., & Levy, D. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.02.003 · Cited by 106 · see citing works
Self-citationCohort description: The Danish study of Functional Disorders
Dantoft, T. M., Ebstrup, J. F., Linneberg, A. R., Skovbjerg, S., Madsen, A. L., Mehlsen, J., Brinth, L. S., Eplov, L. F., Carstensen, T. B. W., Schröder, A., et al. (2017) · Clinical Epidemiology · doi:10.2147/clep.s129335 · Cited by 108 · see citing works
Perivascular Adipose Tissue as a Relevant Fat Depot for Cardiovascular Risk in Obesity
da Costa, R. M., Neves, K. B., Tostes, R. C., & Lobato, N. S. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00253 · Cited by 107 · see citing works
Alotaibi, B. S., Ijaz, M., Buabeid, M. A., Kharaba, Z. J., Yaseen, H. S., & Murtaza, G. (2021) · Drug Design Development and Therapy · doi:10.2147/dddt.s327238 · Cited by 106 · see citing works
Ahuja, S. K., Manoharan, M. S., Lee, G. C., McKinnon, L. R., Meunier, J. A., Steri, M., Harper, N., Fiorillo, E., Smith, A. M., Restrepo, M. I., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38238-6 · Cited by 106 · see citing works
Meneton, P., Kesse-Guyot, E., Méjean, C., Fezeu, L., Galan, P., Hercberg, S., & Ménard, J. (2015) · International Archives of Occupational and Environmental Health · doi:10.1007/s00420-014-0997-7 · Cited by 105 · see citing works
The application of big data to cardiovascular disease: paths to precision medicine
Leopold, J. A., Maron, B. A., & Loscalzo, J. (2020) · Journal of Clinical Investigation · doi:10.1172/jci129203 · Cited by 105 · see citing works
Lifestyle Medicine and the Management of Cardiovascular Disease
Doughty, K. N., Pilar, N. X. D., Audette, A., & Katz, D. L. (2017) · Current Cardiology Reports · doi:10.1007/s11886-017-0925-z · Cited by 104 · see citing works
Vascular ageing: Underlying mechanisms and clinical implications
Laina, A., Stellos, K., & Stamatelopoulos, K. S. (2017) · Experimental Gerontology · doi:10.1016/j.exger.2017.06.007 · Cited by 103 · see citing works
Prevalence and nature of cardiovascular disease in methamphetamine-related death: A national study
Darke, S. G., Duflou, J. A., & Kaye, S. S. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.07.001 · Cited by 100 · see citing works
Timeline of History of Hypertension Treatment
Saklayen, M. G., & Deshpande, N. V. (2016) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2016.00003 · Cited by 96 · see citing works
Wang, B., Liu, S., Li, L., Yao, Q., Song, R., Shao, X., Li, Q., Shi, X., & Zhang, J. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.10.039 · Cited by 96 · see citing works
Diet and Cardiovascular Disease: Advances and Challenges in Population-Based Studies
Pan, A., Lin, X., Hemler, E. C., & Hu, F. B. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.02.017 · Cited by 96 · see citing works
Andersson, C., Nayor, M. G., Tsao, C. W., Levy, D. A., & Vasan, R. S. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.01.059 · Cited by 94 · see citing works
Self-citationRalapanawa, U., Kumarasiri, P. V. R., Jayawickreme, K. P., Kumarihamy, P., Wijeratne, Y. M. T. Y., Ekanayake, E. M. M., & Dissanayake, C. (2019) · BMC Cardiovascular Disorders · doi:10.1186/s12872-019-1217-x · Cited by 91 · see citing works
Jonnagaddala, J., Liaw, S., RAY, P. K., Kumar, M., Chang, N., & Dai, H.-J. (2015) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2015.08.003 · Cited by 89 · see citing works
Veronese, N., Stubbs, B., Noale, M., Solmi, M., Luchini, C., Smith, T. O., Cooper, C. C., Guglielmi, G., Reginster, J., Rizzoli, R., et al. (2016) · Clinical Nutrition · doi:10.1016/j.clnu.2016.09.035 · Cited by 89 · see citing works
Nakaji, S., Ihara, K., Sawada, K., Parodi, S., Umeda, T., Takahashi, I., Murashita, K., Kurauchi, S., & Tokuda, I. (2021) · SAGE Open Medicine · doi:10.1177/20503121211002606 · Cited by 88 · see citing works
Effects of boron-containing compounds on cardiovascular disease risk factors – A review
Donoiu, I., Militaru, C., Obleagă, O., Hunter, J. M., Neamţu, J., Biţă, A., Scorei, I. R., & Rogoveanu, O. C. (2018) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2018.06.003 · Cited by 85 · see citing works
The promises and pitfalls of sex difference research
Galea, L. A. M., Choleris, E., Albert, A., McCarthy, M. M., & Sohrabji, F. (2019) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2019.100817 · Cited by 85 · see citing works
The Story of the Silent Killer
Kalehoff, J. P., & Oparil, S. (2020) · Current Hypertension Reports · doi:10.1007/s11906-020-01077-7 · Cited by 85 · see citing works
Wang, T., Zhao, Z., Yu, X., Zeng, T., Xu, M., Xu, Y., Hu, R., Chen, G., Su, Q., Mu, Y., et al. (2021) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2021.100277 · Cited by 84 · see citing works
Self-citationLow oxygen saturation and mortality in an adult cohort: the Tromsø study
Vold, M. L., Aasebø, U., Wilsgaard, T., & Melbye, H. (2015) · BMC Pulmonary Medicine · doi:10.1186/s12890-015-0003-5 · Cited by 83 · see citing works
Kee, O. T., Harun, H., Mustafa, N., Abdul Murad, N. A., Chin, S. F., Jaafar, R., & Abdullah, N. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01741-7 · Cited by 82 · see citing works
Więckowska, B., Kubiak, K. B., Jóźwiak, P., Moryson, W., & Stawińska-Witoszyńska, B. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191610213 · Cited by 82 · see citing works
Big data and artificial intelligence in cancer research
Wu, X., Li, W., & Tu, H. (2023) · Trends in cancer · doi:10.1016/j.trecan.2023.10.006 · Cited by 81 · see citing works
Tielemans, S. M. A. J., Geleijnse, J. M., Menotti, A., Boshuizen, H. C., Soedamah‐Muthu, S. S., Jacobs, D. R., BLACKBURN, H. W., & Kromhout, D. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.114.001378 · Cited by 81 · see citing works
Veronese, N., Stubbs, B., Noale, M., Solmi, M., Rizzoli, R., Vaona, A., Demurtas, J., Crepaldi, G., & Maggi, S. (2018) · Clinical Nutrition · doi:10.1016/j.clnu.2017.08.028 · Cited by 80 · see citing works
Wang, F., Yu, Y., Mubarik, S., Zhang, Y., Liu, X., Cheng, Y., Yu, C., & Cao, J. (2021) · Clinical Epidemiology · doi:10.2147/clep.s317787 · Cited by 80 · see citing works
Atherosclerosis and Coronary Artery Disease
Zaromitidou, M., Siasos, G., Παπαγεωργίου, Ν., Oikonomou, E. K., & Tousoulis, D. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803312-8.00002-1 · Cited by 80 · see citing works
The imperative for health promotion in universal health coverage
Coe, G., & de Beyer, J. (2014) · Global Health Science and Practice · doi:10.9745/ghsp-d-13-00164 · Cited by 79 · see citing works
Preclinical Alzheimer's disease: A systematic review of the cohorts underlying the concept
Epelbaum, S., Genthon, R., Cavedo, E., Habert, M. O., Lamari, F., Gagliardi, G. P., Lista, S., Teichmann, M., Bakardjian, H., Hampel, H. J., et al. (2017) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.12.003 · Cited by 77 · see citing works
Proteomic profiling reveals biomarkers and pathways in type 2 diabetes risk
Ngo, D., Benson, M. D., Long, J. Z., Chen, Z., Wang, R., Nath, A. K., Keyes, M. J., Shen, D., Sinha, S., Kuhn, E. W., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.144392 · Cited by 76 · see citing works
Self-citationMatteis, C. D., Cariello, M., Graziano, G., Battaglia, S., Suppressa, P., Piazzolla, G., Sabbà, C., & Moschetta, A. (2021) · Scientific Reports · doi:10.1038/s41598-021-94277-3 · Cited by 76 · see citing works
Cohort profile: The Rugao Longevity and Ageing Study (RuLAS)
Liu, Z., Wang, Y., Zhang, Y., Chu, X., Wang, Z., Qian, D., Chen, F., Xu, J., Li, S., Li, J., et al. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv101 · Cited by 76 · see citing works
Drager, L. F., Santos, R. B., Silva, W. A., Parise, B. K., Giatti, S., Aielo, A. N., Souza, S. P., Furlan, S. F., Lorenzi‐Filho, G., Lotufo, P. A., et al. (2019) · CHEST Journal · doi:10.1016/j.chest.2018.12.003 · Cited by 76 · see citing works
Qureshi, N. Q., Mufarrih, S. H., Bloomfield, G. S., Tariq, W., Almas, A., Mokdad, A. H., Bartlett, J. A., Nisar, M. I., Siddiqi, S., Bhutta, Z. A., et al. (2021) · Global Heart · doi:10.5334/gh.815 · Cited by 74 · see citing works
Shaked, I., Hanna, D. B., Gleißner, C., Marsh, B. J., Plants, J., Tracy, D., Anastos, K., Cohen, M. H., Golub, E. T., Karim, R., et al. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.303153 · Cited by 73 · see citing works
Effect of Glucose Levels on Cardiovascular Risk
Poznyak, A. V., Litvinova, L. S., Poggio, P., Sukhorukov, V. N., & Orekhov, A. N. (2022) · Cells · doi:10.3390/cells11193034 · Cited by 73 · see citing works
Circulating exosomal miRNAs in cardiovascular disease pathogenesis: New emerging hopes
Aghabozorgi, A. S., Ahangari, N., Eftekhaari, T. E., Torbati, P. N., Bahiraee, A., Ebrahimi, R., & Pasdar, A. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28942 · Cited by 73 · see citing works
Artificial intelligence for dementia—Applied models and digital health
Lyall, D. M., Kormilitzin, A., Lancaster, C. L., Sousa, J., Petermann-Rocha, F. E., Buckley, C., Harshfield, E. L., Iveson, M. H., Madan, C. R., Ardle, R. M., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13391 · Cited by 72 · see citing works
Ferreira, P., Spolidório, L. C., Manthey, J. A., & Cesar, T. B. (2016) · Food & Function · doi:10.1039/c5fo01541c · Cited by 72 · see citing works
Yashin, A. I., Fang, F., Kovtun, M., Wu, D., Duan, M., Arbeev, K. G., Akushevich, I. V., Kulminski, A. M., Culminskaya, I. V., Zhbannikov, I. Y., et al. (2017) · Experimental Gerontology · doi:10.1016/j.exger.2017.10.020 · Cited by 72 · see citing works
The importance of cohort studies in the post-GWAS era
Wijmenga, C., & Zhernakova, A. (2018) · Nature Genetics · doi:10.1038/s41588-018-0066-3 · Cited by 72 · see citing works
- Authors
- Mahmood, S. S., Levy, D., Vasan, R. S., & Wang, T. J.
- Affiliations
- Harvard University (US)
- National Institutes of Health (US)
- Boston University (US)
- Vanderbilt University (US)
- Corresponding author
- Wang, Thomas J
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2014-03
- Volume
- 383
- Issue
- 9921
- Pages
- 999-1008
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- PMC
- PMC4159698
- OpenAlex
- W2030322782
- Semantic Scholar
- a856c8df2f6656167328ccc091cb374a1d152f60
- Cited by
- 1,622
- References
- 86
- Citations by year
- 2026: 98 · 2025: 172 · 2024: 179 · 2023: 175 · 2022: 181 · 2021: 200 · 2020: 149 · 2019: 146 · 2018: 100 · 2017: 89 · 2016: 55 · 2015: 50 · 2014: 27
- FWCI
- 7.50
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- NIH (N01-HC-25195)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Social Sciences › Sociology and Political Science › Historical and modern epidemiology studies
- Health Sciences › Medicine › Epidemiology › Healthcare Systems and Public Health
- Keywords
- Framingham Heart Study, cardiovascular disease epidemiology, cardiovascular risk factors, Franklin D. Roosevelt, hypertensive heart disease, stroke
- MeSH terms
- Cardiovascular Diseases, Epidemiology, Humans, Longitudinal Studies, Massachusetts, Research Support as Topic, Risk Factors, History, 20th Century, History, 21st Century
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-05.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-05.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review